339 related articles for article (PubMed ID: 15905543)
1. IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis.
Gangi E; Vasu C; Cheatem D; Prabhakar BS
J Immunol; 2005 Jun; 174(11):7006-13. PubMed ID: 15905543
[TBL] [Abstract][Full Text] [Related]
2. Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis.
Vasu C; Dogan RN; Holterman MJ; Prabhakar BS
J Immunol; 2003 Jun; 170(11):5511-22. PubMed ID: 12759428
[TBL] [Abstract][Full Text] [Related]
3. GM-CSF-induced CD11c+CD8a--dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis.
Ganesh BB; Cheatem DM; Sheng JR; Vasu C; Prabhakar BS
Int Immunol; 2009 Mar; 21(3):269-82. PubMed ID: 19174473
[TBL] [Abstract][Full Text] [Related]
4. Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells.
Verginis P; Li HS; Carayanniotis G
J Immunol; 2005 Jun; 174(11):7433-9. PubMed ID: 15905592
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
[TBL] [Abstract][Full Text] [Related]
6. H2A- and H2E-derived CD4+CD25+ regulatory T cells: a potential role in reciprocal inhibition by class II genes in autoimmune thyroiditis.
Morris GP; Yan Y; David CS; Kong YC
J Immunol; 2005 Mar; 174(5):3111-6. PubMed ID: 15728527
[TBL] [Abstract][Full Text] [Related]
7. Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody.
Morris GP; Kong YC
J Autoimmun; 2006 Feb; 26(1):24-31. PubMed ID: 16253477
[TBL] [Abstract][Full Text] [Related]
8. Distinctive modulation by IL-4 and IL-10 of the effector function of murine thyroglobulin-primed cells in "transfer-experimental autoimmune thyroiditis".
Mignon-Godefroy K; Brazillet MP; Rott O; Charreire J
Cell Immunol; 1995 May; 162(2):171-7. PubMed ID: 7743543
[TBL] [Abstract][Full Text] [Related]
9. Induction of severe granulomatous experimental autoimmune thyroiditis in mice by effector cells activated in the presence of anti-interleukin 2 receptor antibody.
Braley-Mullen H; Sharp GC; Bickel JT; Kyriakos M
J Exp Med; 1991 Apr; 173(4):899-912. PubMed ID: 1672546
[TBL] [Abstract][Full Text] [Related]
10. Characterization of resistance to murine experimental autoimmune thyroiditis: duration and afferent action of thyroglobulin- and TSH-induced suppression.
Fuller BE; Okayasu I; Simon LL; Giraldo AA; Kong YM
Clin Immunol Immunopathol; 1993 Oct; 69(1):60-8. PubMed ID: 7691454
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis.
Braley-Mullen H; Sharp GC; Tang H; Chen K; Kyriakos M; Bickel JT
Am J Pathol; 1998 May; 152(5):1347-58. PubMed ID: 9588903
[TBL] [Abstract][Full Text] [Related]
12. Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both Th1 and Th2 cytokines.
Tang H; Braley-Mullen H
Int Immunol; 1997 May; 9(5):679-87. PubMed ID: 9184913
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4+CD25+ regulatory T cells.
Wang SH; Chen GH; Fan Y; Van Antwerp M; Baker JR
Endocrinology; 2009 Apr; 150(4):2000-7. PubMed ID: 19008314
[TBL] [Abstract][Full Text] [Related]
14. Naturally-existing CD4(+)CD25(+)Foxp3(+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen.
Morris GP; Brown NK; Kong YC
J Autoimmun; 2009 Aug; 33(1):68-76. PubMed ID: 19375891
[TBL] [Abstract][Full Text] [Related]
15. CD40L is necessary for the priming of effector cells for lymphocytic and granulomatous experimental autoimmune thyroiditis.
Peterson KE; Braley-Mullen H
J Autoimmun; 1999 Feb; 12(1):1-12. PubMed ID: 10028017
[TBL] [Abstract][Full Text] [Related]
16. Targeted engagement of CTLA-4 prevents autoimmune thyroiditis.
Vasu C; Gorla SR; Prabhakar BS; Holterman MJ
Int Immunol; 2003 May; 15(5):641-54. PubMed ID: 12697664
[TBL] [Abstract][Full Text] [Related]
17. Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function.
Cheatem D; Ganesh BB; Gangi E; Vasu C; Prabhakar BS
Clin Immunol; 2009 May; 131(2):260-70. PubMed ID: 19171501
[TBL] [Abstract][Full Text] [Related]
18. Induction of immune tolerance in mice with a novel mucosal nanoemulsion adjuvant and self-antigen.
Wang SH; Fan Y; Makidon PE; Cao Z; Baker JR
Nanomedicine (Lond); 2012 Jun; 7(6):867-76. PubMed ID: 22420425
[TBL] [Abstract][Full Text] [Related]
19. CD137 signaling interferes with activation and function of CD4+CD25+ regulatory T cells in induced tolerance to experimental autoimmune thyroiditis.
Morris GP; Chen L; Kong YC
Cell Immunol; 2003 Nov; 226(1):20-9. PubMed ID: 14746804
[TBL] [Abstract][Full Text] [Related]
20. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent.
Kearley J; Barker JE; Robinson DS; Lloyd CM
J Exp Med; 2005 Dec; 202(11):1539-47. PubMed ID: 16314435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
